부산대학교 도서관

Aggour, Kareem S.; Kumar, Vijay S.; Sangurdekar, Dipen P.; Newberg, Lee A.; Kodira, Chinnappa D.

2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) Bioinformatics and Biomedicine (BIBM), 2015 IEEE International Conference on. :756-763 Nov, 2015

Dodson AE; KSQ Therapeutics, Lexington, Massachusetts.; Shenker S; KSQ Therapeutics, Lexington, Massachusetts.; Sullivan P; KSQ Therapeutics, Lexington, Massachusetts.; Nayak SU; KSQ Therapeutics, Lexington, Massachusetts.; Middleton C; KSQ Therapeutics, Lexington, Massachusetts.; McGuire M; KSQ Therapeutics, Lexington, Massachusetts.; Chipumuro E; KSQ Therapeutics, Lexington, Massachusetts.; Mishina Y; KSQ Therapeutics, Lexington, Massachusetts.; Tobin ER; KSQ Therapeutics, Lexington, Massachusetts.; Cadzow L; KSQ Therapeutics, Lexington, Massachusetts.; Wylie AA; KSQ Therapeutics, Lexington, Massachusetts.; Sangurdekar D; KSQ Therapeutics, Lexington, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

Brooke Rhead; Ina S Brorson; Tone Berge; Cameron Adams; Hong Quach; Stine Marit Moen; Pål Berg-Hansen; Elisabeth Gulowsen Celius; Dipen P Sangurdekar; Paola G Bronson; Rodney A Lea; Sean Burnard; Vicki E Maltby; Rodney J Scott; Jeannette Lechner-Scott; Hanne F Harbo; Steffan D Bos; Lisa F Barcellos

PLoS ONE, Vol 13, Iss 10, p e0206511 (2018)

Cadzow L; KSQ Therapeutics, Lexington, Massachusetts.; Brenneman J; KSQ Therapeutics, Lexington, Massachusetts.; Tobin E; KSQ Therapeutics, Lexington, Massachusetts.; Sullivan P; KSQ Therapeutics, Lexington, Massachusetts.; Nayak S; KSQ Therapeutics, Lexington, Massachusetts.; Ali JA; KSQ Therapeutics, Lexington, Massachusetts.; Shenker S; KSQ Therapeutics, Lexington, Massachusetts.; Griffith J; KSQ Therapeutics, Lexington, Massachusetts.; McGuire M; KSQ Therapeutics, Lexington, Massachusetts.; Grasberger P; KSQ Therapeutics, Lexington, Massachusetts.; Mishina Y; KSQ Therapeutics, Lexington, Massachusetts.; Murray M; KSQ Therapeutics, Lexington, Massachusetts.; Dodson AE; KSQ Therapeutics, Lexington, Massachusetts.; Gannon H; KSQ Therapeutics, Lexington, Massachusetts.; Krall E; KSQ Therapeutics, Lexington, Massachusetts.; Hixon J; KSQ Therapeutics, Lexington, Massachusetts.; Chipumuro E; KSQ Therapeutics, Lexington, Massachusetts.; Sinkevicius K; KSQ Therapeutics, Lexington, Massachusetts.; Gokhale PC; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ganapathy S; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Matulonis UA; Dana Farber Cancer Institute, Boston, Massachusetts.; Liu JF; Dana Farber Cancer Institute, Boston, Massachusetts.; Olaharski A; KSQ Therapeutics, Lexington, Massachusetts.; Sangurdekar D; KSQ Therapeutics, Lexington, Massachusetts.; Liu H; KSQ Therapeutics, Lexington, Massachusetts.; Wilt J; KSQ Therapeutics, Lexington, Massachusetts.; Schlabach M; KSQ Therapeutics, Lexington, Massachusetts.; Stegmeier F; KSQ Therapeutics, Lexington, Massachusetts.; Wylie AA; KSQ Therapeutics, Lexington, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Fox RJ; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Cree BAC; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; de Sèze J; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Gold R; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Hartung HP; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Jeffery D; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Kappos L; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Montalban X; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Weinstock-Guttman B; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Singh CM; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Altincatal A; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Belviso N; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Avila RL; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Ho PR; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Su R; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Engle R; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Sangurdekar D; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; de Moor C; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Fisher E; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Kieseier BC; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.; Rudick RA; From the Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH; Department of Neurology (B.A.C.C.), Weill Institute for Neurosciences, University of California San Francisco; Department of Neurology (J.S.), Hôpital Civil, Strasbourg, France; Department of Neurology (R.G.), St. Josef Hospital, Ruhr University, Bochum, Germany; Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Palacky University Olomouc, Czech Republic; Piedmont HealthCare (D.J.), Mooresville, NC; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center (L.K.); Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs Multiple Sclerosis Center and Pediatric Multiple Sclerosis Center of Excellence (B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; and Biogen (C.M.S., A.A., N.B., R.L.A., P.-R.H., R.S., R.E., D.S., C.M., E.F., B.C.K., R.A.R.), Cambridge, MA.

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

Calabresi PA; Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.; Arnold DL; Montreal Neurological Institute, McGill University, Montreal, QC, Canada/NeuroRx, Montreal, QC, Canada.; Sangurdekar D; Biogen, Cambridge, MA, USA.; Singh CM; Biogen, Cambridge, MA, USA.; Altincatal A; Biogen, Cambridge, MA, USA.; de Moor C; Biogen, Cambridge, MA, USA.; Engle B; Biogen, Cambridge, MA, USA.; Goyal J; Biogen, Cambridge, MA, USA.; Deykin A; Biogen, Cambridge, MA, USA.; Szak S; Biogen, Cambridge, MA, USA.; Kieseier BC; Department of Neurology, Medical Faculty, Heinrich Heine University, Dusseldorf, Germany/Biogen, Cambridge, MA, USA.; Rudick RA; Biogen, Cambridge, MA, USA.; Plavina T; Biogen, Cambridge, MA, USA.

Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Sejbaek, T.; Penner, N.; Plavina, T.; Mendoza, J. P.; Sangurdekar, D.; Nielsen, H. Hvilsted; Martin, N. A.; Elkjaer, M. L.; Ravnborg, M.; Illes, Z.

Sejbaek, T, Penner, N, Plavina, T, Mendoza, J P, Sangurdekar, D, Nielsen, H H, Martin, N A, Elkjaer, M L, Ravnborg, M & Illes, Z 2018, ' Dimethyl fumarate decreases neurofilament light chain levels in CSF and blood ', Multiple Sclerosis Journal, vol. 24, no. 2, pp. 452 .

David Monteiro; Meghan Travers; Tyler G. Searles; Gustavo J. Martinez; Sharon Lin; Ashish Yeri; Alex Smashnov; Mitali Ghose; Seamus McKenney; Paul Dunbar; Charles H. Yoon; Dipen Sangurdekar; Karrie Wong; Joseph D. Phillips; Mary Jo Turk; Micah J. Benson

Cancer Research. 85:2196-2196

G N, Vemuri; E, Altman; D P, Sangurdekar; A B, Khodursky; M A, Eiteman

Applied and Environmental Microbiology. 72:3653-3661

Plavina T; Biogen, Cambridge, Massachusetts.; Singh CM; Biogen, Cambridge, Massachusetts.; Sangurdekar D; Biogen, Cambridge, Massachusetts.; de Moor C; Biogen, Cambridge, Massachusetts.; Engle B; Biogen, Cambridge, Massachusetts.; Gafson A; Biogen, Cambridge, Massachusetts.; Goyal J; Biogen, Cambridge, Massachusetts.; Fisher E; Biogen, Cambridge, Massachusetts.; Szak S; Biogen, Cambridge, Massachusetts.; Kinkel RP; Department of Neurosciences, University of California, San Diego.; Sandrock AW; Biogen, Cambridge, Massachusetts.; Su R; Biogen, Cambridge, Massachusetts.; Kieseier BC; Biogen, Cambridge, Massachusetts.; Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.; Rudick RA; Biogen, Cambridge, Massachusetts.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Kuhle J; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.; Plavina T; Biogen, Cambridge, MA, USA.; Barro C; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.; Disanto G; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland/Neurocenter of Southern Switzerland, Ospedale Civico, Lugano, Switzerland.; Sangurdekar D; Biogen, Cambridge, MA, USA.; Singh CM; Biogen, Cambridge, MA, USA.; de Moor C; Biogen, Cambridge, MA, USA.; Engle B; Biogen, Cambridge, MA, USA.; Kieseier BC; Biogen, Cambridge, MA, USA.; Fisher E; Biogen, Cambridge, MA, USA.; Kappos L; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.; Rudick RA; Biogen, Cambridge, MA, USA.; Goyal J; Biogen, Cambridge, MA, USA.

Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Fox, R.; Cree, B. A. C.; De Seze, J.; Gold, R.; Hartung, H. -P.; Jeffery, D.; Kappos, L.; Montalban, X.; Weinstock-Guttman, B.; Singh, C. M.; Campbell, N.; Ho, P. -R.; Su, R.; Engle, B.; Sangurdekar, D.; de Moor, C.; Fisher, E.; Kieseier, B. C.; Rudick, R. A.; Plavina, T.

MULTIPLE SCLEROSIS JOURNAL; OCT 2018, 24 p244-p246, 3p. Supplement: 2

Sangurdekar D; Translational Genome Sciences, Translational Biology, Biogen, Cambridge, MA, United States.; Sun C; Translational Genome Sciences, Translational Biology, Biogen, Cambridge, MA, United States.; McLaughlin H; Human Target Validation Core, Translational Biology, Biogen, Cambridge, MA, United States.; Ayling-Rouse K; Envision Pharma Group, Horsham, United Kingdom.; Allaire NE; Translational Genome Sciences, Translational Biology, Biogen, Cambridge, MA, United States.; Penny MA; Translational Genome Sciences, Translational Biology, Biogen, Cambridge, MA, United States.; Bronson PG; Human Target Validation Core, Translational Biology, Biogen, Cambridge, MA, United States.

Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101560621 Publication Model: eCollection Cited Medium: Print ISSN: 1664-8021 (Print) Linking ISSN: 16648021 NLM ISO Abbreviation: Front Genet Subsets: PubMed not MEDLINE

Bame E; Clinical Sciences Biogen Cambridge MA USA.; Tang H; Biogen Research Biogen Cambridge MA USA.; Burns JC; Biogen Research Biogen Cambridge MA USA.; Arefayene M; Clinical Sciences Biogen Cambridge MA USA.; Michelsen K; Biotherapeutics and Medicinal Sciences Biogen Cambridge MA USA.; Present address: Relay Therapeutics Cambridge MA USA.; Ma B; Biotherapeutics and Medicinal Sciences Biogen Cambridge MA USA.; Marx I; Biotherapeutics and Medicinal Sciences Biogen Cambridge MA USA.; Prince R; Biotherapeutics and Medicinal Sciences Biogen Cambridge MA USA.; Roach AM; Biogen Research Biogen Cambridge MA USA.; Present address: Gilead Sciences Seattle WA USA.; Poreci U; Clinical Sciences Biogen Cambridge MA USA.; Present address: Pandion Therapeutics Watertown MA USA.; Donaldson D; Clinical Sciences Biogen Cambridge MA USA.; Present address: Giner Labs Newton MA USA.; Cullen P; Biogen Research Biogen Cambridge MA USA.; Casey F; Biogen Research Biogen Cambridge MA USA.; Zhu J; Biogen Research Biogen Cambridge MA USA.; Carlile TM; Biogen Research Biogen Cambridge MA USA.; Sangurdekar D; Biogen Research Biogen Cambridge MA USA.; Present address: Takeda Cambridge MA USA.; Zhang B; Biogen Research Biogen Cambridge MA USA.; Trapa P; Biotherapeutics and Medicinal Sciences Biogen Cambridge MA USA.; Santoro J; Biotherapeutics and Medicinal Sciences Biogen Cambridge MA USA.; Muragan P; Biotherapeutics and Medicinal Sciences Biogen Cambridge MA USA.; Pellerin A; Biogen Research Biogen Cambridge MA USA.; Rubino S; Biogen Research Biogen Cambridge MA USA.; Gianni D; Biotherapeutics and Medicinal Sciences Biogen Cambridge MA USA.; Bajrami B; Biotherapeutics and Medicinal Sciences Biogen Cambridge MA USA.; Peng X; Global Safety and Regulatory Sciences Biogen Cambridge MA USA.; Coppell A; Clinical Operations Biogen Maidenhead UK.; Riester K; Clinical Sciences Biogen Cambridge MA USA.; Belachew S; Personalized Health Research Biogen Baar Switzerland.; Mehta D; Clinical Sciences Biogen Cambridge MA USA.; Present address: Immunologix Laboratories Cambridge MA USA.; Palte M; MS Development Unit Biogen Cambridge MA USA.; Hopkins BT; Biotherapeutics and Medicinal Sciences Biogen Cambridge MA USA.; Scaramozza M; MS Development Unit Biogen Cambridge MA USA.; Franchimont N; MS Development Unit Biogen Cambridge MA USA.; Mingueneau M; Biogen Research Biogen Cambridge MA USA.

Publisher: John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc Country of Publication: Australia NLM ID: 101638268 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0068 (Print) Linking ISSN: 20500068 NLM ISO Abbreviation: Clin Transl Immunology Subsets: PubMed not MEDLINE

Martin, Nathan ; Thompson, Ethan G. ; Brown, Will ; Finney, Olivia ; Rytlewski, Julie ; Jiang, Yue ; Sangurdekar, Dipen ; Wang, Julie ; Bitter, Hans ; Hause, Ronald J., Jr. ; Campbell, Timothy B. ; Hege, Kristen ; Kaiser, Shari

In Blood 5 November 2020 136 Supplement 1:17-18

Calabresi, P.; Kuhle, J.; Arnold, D. L.; Singh, C. M.; Kinkel, R. P.; Kappos, L.; Sangurdekar, D.; de Moor, C.; Engle, B.; Su, R.; Deykin, A.; Fisher, E.; Sandrock, A.; Kieseier, B. C.; Rudick, R. A.; Plavina, T.

MULTIPLE SCLEROSIS JOURNAL; OCT 2018, 24 p59-p60, 2p. Supplement: 2

Zare H; Department of Biochemistry, Biophysics and Molecular Biology, The University of Minnesota, St, Paul, MN, USA. hossein@umn.edu; Sangurdekar D; Srivastava P; Kaveh M; Khodursky A

Publisher: BioMed Central Country of Publication: England NLM ID: 101301827 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-0509 (Electronic) Linking ISSN: 17520509 NLM ISO Abbreviation: BMC Syst Biol Subsets: MEDLINE

Calabresi, P. A.; Arnold, D. A.; Sangurdekar, D.; Singh, C. M.; De Moor, C.; Engle, B.; Goyal, J.; Deykin, A.; Fisher, E.; Kieseier, B. C.; Rudick, R. A.; Plavina, T.

MULTIPLE SCLEROSIS JOURNAL; OCT 2017, 23 p24-p25, 2p. Supplement: 3

Kapoor, R.; Sellebjerg, F.; Hartung, H. -P.; Arnold, D. L.; Freedman, M. S.; Jeffery, D.; Miller, A.; Edwards, K. R.; Singh, C. M.; Chang, I.; Ren, Z.; Sangurdekar, D.; Zhu, B.; Sheikh, S.; Mehta, D.; Ho, P. -R.; Campbell, N.; Edwards, M.; Fisher, E.; Kieseier, B. C.; Rudick, R. A.; Plavina, T.

MULTIPLE SCLEROSIS JOURNAL; OCT 2018, 24 p988-p988, 1p. Supplement: 2

Brorson, I. S.; Rhead, B.; Berge, T.; Adams, C.; Quach, H.; Moen, S. M.; Berg-Hansen, P.; Celius, E. G.; Sangurdekar, D. P.; Bronson, P. G.; Lea, R. A.; Burnard, S.; Maltby, V. E.; Scott, R. J.; Lechner-Scott, J.; Harbo, H. F.; Bos, S. D.; Barcellos, L. F.

MULTIPLE SCLEROSIS JOURNAL; OCT 2018, 24 p592-p592, 1p. Supplement: 2